Management of moderate to severe psoriasis with brodalumab-Real-world evidence from the LIBERO study.

R von KiedrowskiT HinzG MauerA SchwinnA TimmelH J HuttMatthias Augustin

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)

This representative, non-interventional study confirms the short- and long-term effectiveness and safety profile of brodalumab in the management of psoriasis in daily practice as well as in relevant treatment pathways.

Keyphrases

healthcare
primary care
high intensity
early onset
smoking cessation